Hcw Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.34

-0.01 (-3.55%)

As of May 16, 2:35 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,739.8% upside

Low Target $12.72

Average Target $19.68

High Target $25.92

Current Price $0.34

Current
$0.34

Target
$19.68

$12.72 $19.68 avg $25.92

Scenario Analysis

Bear Case

$12.72

3,674.5%

Low target

Base Case

$19.68

+5,739.8%

Avg target

Bull Case

$25.92

+7,591.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$11.22

-97.0% from high

52-Week Low

$0.25

+34.8% from low

Target vs 52W High

$19.68

+75.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%